Black Diamond Therapeutics, Inc. (BDTX) Covered Calls

You can sell covered calls on Black Diamond Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BDTX (prices last updated Fri 4:16 PM ET):

Black Diamond Therapeutics, Inc. (BDTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
2.62 -0.23 2.62 2.75 438K - 0.2
Covered Calls For Black Diamond Therapeutics, Inc. (BDTX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 2.5 0.00 2.75 -9.1% -92.3%
Jan 17 2.5 0.00 2.75 -9.1% -51.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Black Diamond Therapeutics, Inc., a precision oncology medicine company, discovers and develops small molecule, tumor-agnostic therapies. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various early stage pipeline programs targeting allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.